tiprankstipranks
Trending News
More News >
Santhera Pharmaceuticals Holding (SPHDF)
OTHER OTC:SPHDF

Compare Santhera Pharmaceuticals Holding (SPHDF) vs. Competitors

Compare
39 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Compare
Top Analysts' Price Target
Smart Score
Follow
Santhera Pharmaceuticals Holding
$17.90
$251.33M
-0.98
5.60%
1 Buy
0 Hold
0 Sell
Moderate Buy
Molecular Partners AG
CHF3.41
CHF145.75M
-2.05
1.40%
1 Buy
0 Hold
0 Sell
Moderate Buy
Basilea Pharmaceutica
CHF52.60
CHF634.73M
16.63
5.05%
1 Buy
0 Hold
0 Sell
Moderate Buy
Idorsia Ltd
CHF3.08
CHF791.95M
-8.17
178.99%
2 Buy
0 Hold
0 Sell
Moderate Buy
Newron Pharmaceuticals SpA
CHF14.60
CHF303.08M
-487.07
71.56%
1 Buy
0 Hold
0 Sell
Moderate Buy
Xlife Sciences Ltd.
CHF21.30
CHF126.89M
4.08
16.71%

Performance Comparison

Ticker
Company Name
Price
Change
% Change
SPHDF
Santhera Pharmaceuticals Holding
17.90
1.50
9.15%
CH:MOLN
Molecular Partners AG
3.61
0.10
3.00%
CH:BSLN
Basilea Pharmaceutica
51.00
3.65
7.71%
CH:IDIA
Idorsia Ltd
3.08
2.01
188.66%
CH:NWRN
Newron Pharmaceuticals SpA
14.60
6.19
73.60%
CH:XLS
Xlife Sciences Ltd.
22.00
1.70
8.37%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts